• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Strados Labs and BIDMC Launch Study to Evaluate AI-Powered Biosensor for Early Detection of Pulmonary Edema

by Jasmine Pennic 02/21/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

   

What You Should Know: 

– Strados Labs, a medical technology company focused on respiratory health, today announced a new collaboration with Beth Israel Deaconess Medical Center (BIDMC) to evaluate the use of its RESP® Biosensor for the early detection of pulmonary edema in critically ill patients.

– The pilot study, scheduled to begin at the end of February 2025, will enroll 20 patients and is expected to last 12 months.

Study Design and Objectives

Pulmonary edema, a condition where fluid accumulates in the lungs, is a common and life-threatening complication for patients on mechanical ventilation (MV). Early detection is crucial for effective intervention and improved outcomes. This study will investigate whether the RESP Biosensor, a wearable stethoscope technology, can detect subtle changes in lung sounds that precede traditional markers of pulmonary edema.

This single-center, prospective, observational study will compare the performance of the RESP Biosensor to existing monitoring methods, such as daily chest X-rays, clinical assessments, and fluid intake/output tracking. The primary objective is to determine if the biosensor can identify early signs of pulmonary edema before they are detectable through conventional methods.

RESP Biosensor: A Breakthrough in Continuous Lung Monitoring

The RESP Biosensor is an FDA-cleared and CE-marked wearable device that continuously captures lung sounds, including cough, wheeze, and crackles. This technology has been used in various patient populations and disease states, such as chronic cough, COPD, asthma, and heart failure. This study marks the first time the RESP Biosensor will be used to monitor patients on MV for pulmonary edema.

Expanding Applications for Lung Sound Monitoring

This study is part of a broader effort to evaluate the potential of the RESP Biosensor to improve patient care across various respiratory conditions. The findings are expected to guide future research and expand the applications of continuous lung sound monitoring.

“Pulmonary edema presents significant challenges in the ICU, with delayed detection often leading to poorer outcomes for patients,” said Nick Delmonico, CEO & Cofounder at Strados Labs. “We’re excited to collaborate with the esteemed team at BIDMC to explore whether continuous monitoring of lung sounds could lead to earlier and prompt interventions in pulmonary edema.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Artificial Intelligence, Biosensors

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

Bayer Exits Radiology AI Market, Discontinuing Calantic and Blackford

Bayer Exits Radiology AI Market, Discontinuing Calantic and Blackford

Oracle Health Launches AI Center of Excellence for Healthcare

Oracle Health Launches AI Center of Excellence for Healthcare

Particle Health Addresses Integration to Epic Data Despite Dispute

US Court Allows Particle’s Antitrust Claims Against Epic to Proceed

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Evernorth Health Services Invests $3.5B in Shields Health Solutions

Evernorth Health Services Invests $3.5B in Shields Health Solutions

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

M&A:Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

Femtech: Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |